Fissell William H, Roy Shuvo
Department of Nephrology, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Semin Dial. 2009 Nov-Dec;22(6):665-70. doi: 10.1111/j.1525-139X.2009.00662.x.
The confluence of an increasing prevalence of end-stage renal disease (ESRD), clinical trial data suggestive of benefit from quotidian dialysis, and ongoing cost/benefit reanalysis of healthcare spending have stimulated interest in technological improvements in provision of ESRD care. For the last decade, our group has focused on enabling technologies that would permit a paradigm shift in dialysis care similar to that brought by implantable defibrillators to arrhythmia management. Two significant barriers to wearable or implantable dialysis persist: package size of the dialyzer and water requirements for preparation of dialysate. Decades of independent research into highly efficient membranes and cell-based bioreactors culminated in a team effort to develop an implantable version of the University of Michigan Renal Assist Device. In this review, the rationale for the design of the implantable artificial kidney is described.
终末期肾病(ESRD)患病率不断上升、临床试验数据表明每日透析有益,以及对医疗保健支出持续进行的成本/效益再分析,这些因素共同激发了人们对改善ESRD护理技术的兴趣。在过去十年中,我们团队专注于开发相关技术,以使透析护理实现范式转变,类似于植入式除颤器给心律失常管理带来的变革。可穿戴或植入式透析仍存在两个重大障碍:透析器的封装尺寸以及制备透析液所需的水量。数十年来,针对高效膜和基于细胞的生物反应器的独立研究,最终促成了一个团队共同努力开发密歇根大学肾脏辅助装置的植入式版本。在这篇综述中,将描述植入式人工肾脏的设计原理。